Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NMNAT2 anticorps (AA 1-153) (HRP)

NMNAT2 Reactivité: Humain ELISA Hôte: Lapin Polyclonal HRP
N° du produit ABIN7161583
  • Antigène Voir toutes NMNAT2 Anticorps
    NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))
    Épitope
    • 6
    • 6
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    AA 1-153
    Reactivité
    • 28
    • 1
    • 1
    Humain
    Hôte
    • 22
    • 5
    • 1
    Lapin
    Clonalité
    • 24
    • 4
    Polyclonal
    Conjugué
    • 12
    • 5
    • 4
    • 3
    • 2
    • 2
    Cet anticorp NMNAT2 est conjugé à/à la HRP
    Application
    • 25
    • 19
    • 5
    • 1
    ELISA
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 protein (1-153AA)
    Isotype
    IgG
    Top Product
    Discover our top product NMNAT2 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))
    Autre désignation
    NMNAT2 (NMNAT2 Produits)
    Synonymes
    anticorps zgc:73048, anticorps wu:fj59g01, anticorps NMNAT2, anticorps C1orf15, anticorps PNAT2, anticorps AI843915, anticorps D030041I09Rik, anticorps PNAT1, anticorps nicotinamide nucleotide adenylyltransferase 2, anticorps nmnat2, anticorps NMNAT2, anticorps Nmnat2
    Sujet

    Background: Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form, nicotinic acid mononucleotide (NaMN) as substrate but with a lower efficiency. Cannot use triazofurin monophosphate (TrMP) as substrate. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+). For the pyrophosphorolytic activity prefers NAD(+), NADH and NaAD as substrates and degrades nicotinic acid adenine dinucleotide phosphate (NHD) less effectively. Fails to cleave phosphorylated dinucleotides NADP(+), NADPH and NaADP(+).

    Aliases: C1orf15 antibody, KIAA0479 antibody, MGC2756 antibody, NaMN adenylyltransferase 2 antibody, Nicotinamide mononucleotide adenylyltransferase 2 antibody, Nicotinamide nucleotide adenylyltransferase 2 antibody, Nicotinate-nucleotide adenylyltransferase 2 antibody, NMN adenylyltransferase 2 antibody, NMNA2_HUMAN antibody, NMNAT 2 antibody, Nmnat2 antibody, PNAT 2 antibody, PNAT2 antibody, Pyridine nucleotide adenylyltransferase 2 antibody

    UniProt
    Q9BZQ4
Vous êtes ici: